By Reuters Staff1 Min ReadSept 28 (Reuters) – Oxford Nanopore IPO-ONT.L has priced its London initial public offering at 425 pence per share, a bookrunner said on Tuesday, giving it an expected market valuation of around 3.6 billion pounds ($4.92 billion) including its use of a greenshoe option.The IPO of the provider of rapid COVID-19 tests to Britain’s national health services would be significant for the London Stock Exchange as most British pharma and life science companies tend to list on New York’s Nasdaq. ($1 = 0.7311 pounds) (Reporting by Pushkala Aripaka in Bengaluru; Editing by Sriraj Kalluvila)
Related posts:
Esports Entertainment Group Reports Fourth Quarter and Fiscal Year 2021 Results
2021 is set to smash IPO records - Yahoo Finance
Philippine Tycoon Manuel Villar’s AllDay Marts Pegs IPO Price At Lower End Of Range; Still Plans REI...
Fertiglobe IPO price range implies equity value of up to $6 bln - Reuters
